Sino Biopharmaceutical Ltd (1177.HK)
1177.HK on Hong Kong Stock
16.78HKD
25 Apr 2018
16.78HKD
25 Apr 2018
Change (% chg)
HK$0.86 (+5.40%)
HK$0.86 (+5.40%)
Prev Close
HK$15.92
HK$15.92
Open
HK$16.06
HK$16.06
Day's High
HK$16.78
HK$16.78
Day's Low
HK$15.78
HK$15.78
Volume
38,880,293
38,880,293
Avg. Vol
27,711,458
27,711,458
52-wk High
HK$17.46
HK$17.46
52-wk Low
HK$6.17
HK$6.17
Consensus Recommendations
Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
---|---|---|---|
Outperform | 0.08 | December | 25 Apr 2018 |
Analyst Recommendations and Revisions
1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
---|---|---|---|---|
(1) BUY | 8 | 7 | 6 | 5 |
(2) OUTPERFORM | 4 | 4 | 4 | 4 |
(3) HOLD | 4 | 4 | 5 | 5 |
(4) UNDERPERFORM | 1 | 1 | 2 | 3 |
(5) SELL | 1 | 1 | 1 | 1 |
No Opinion | 0 | 0 | 0 | 0 |
Mean Rating | 2.06 | 2.12 | 2.33 | 2.50 |
Consensus Estimates Analysis
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
# of Estimates | Mean | High | Low | 1 Year Ago |
|
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Jun-18 | 2 | 5,064.74 | 5,134.00 | 4,995.48 | -- |
Quarter Ending Sep-18 | 2 | 5,523.52 | 5,589.00 | 5,458.04 | -- |
Year Ending Dec-18 | 18 | 19,086.20 | 21,181.00 | 15,613.00 | 17,005.60 |
Year Ending Dec-19 | 17 | 22,573.70 | 26,575.00 | 16,109.30 | 19,143.10 |
Earnings (per share) | |||||
Quarter Ending Jun-18 | 3 | 0.08 | 0.09 | 0.07 | 0.07 |
Quarter Ending Sep-18 | 3 | 0.11 | 0.12 | 0.10 | 0.07 |
Year Ending Dec-18 | 19 | 0.33 | 0.44 | 0.28 | 0.29 |
Year Ending Dec-19 | 18 | 0.39 | 0.52 | 0.30 | 0.33 |
LT Growth Rate (%) | 2 | 21.66 | 24.00 | 19.33 | 15.36 |
Historical Surprises
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
---|---|---|---|---|
SALES (in millions) | ||||
Quarter Ending Dec-17 | 3,522.68 | 3,372.57 | 150.10 | 4.26 |
Quarter Ending Sep-17 | 4,276.97 | 3,963.87 | 313.10 | 7.32 |
Quarter Ending Jun-17 | 3,659.97 | 3,471.62 | 188.35 | 5.15 |
Quarter Ending Mar-17 | 3,995.39 | 3,916.87 | 78.52 | 1.97 |
Quarter Ending Dec-16 | 3,156.04 | 3,114.20 | 41.83 | 1.33 |
Earnings (per share) | ||||
Quarter Ending Dec-17 | 0.06 | 0.05 | 0.01 | 20.97 |
Quarter Ending Sep-17 | 0.08 | 0.09 | 0.02 | 25.00 |
Quarter Ending Jun-17 | 0.06 | 0.07 | 0.01 | 13.87 |
Quarter Ending Mar-17 | 0.07 | 0.08 | 0.01 | 7.91 |
Quarter Ending Dec-16 | 0.06 | 0.04 | 0.02 | 28.24 |
Consensus Estimates Trend
Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Jun-18 | 5,064.74 | 5,064.74 | 4,576.70 | 4,576.70 | -- |
Quarter Ending Sep-18 | 5,523.52 | 5,523.52 | 5,013.73 | 5,013.73 | -- |
Year Ending Dec-18 | 19,086.20 | 19,086.20 | 18,376.20 | 18,073.20 | 17,005.60 |
Year Ending Dec-19 | 22,573.70 | 22,573.70 | 21,234.80 | 20,834.00 | 19,143.10 |
Earnings (per share) | |||||
Quarter Ending Jun-18 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 |
Quarter Ending Sep-18 | 0.11 | 0.11 | 0.11 | 0.11 | 0.07 |
Year Ending Dec-18 | 0.33 | 0.33 | 0.33 | 0.33 | 0.29 |
Year Ending Dec-19 | 0.39 | 0.39 | 0.39 | 0.39 | 0.33 |
Estimates Revisions Summary
Last Week | Last 4 Weeks | |||
---|---|---|---|---|
Number Of Revisions: | Up | Down | Up | Down |
Revenue | ||||
Quarter Ending Jun-18 | 0 | 0 | 2 | 0 |
Quarter Ending Sep-18 | 0 | 0 | 2 | 0 |
Year Ending Dec-18 | 0 | 0 | 9 | 5 |
Year Ending Dec-19 | 0 | 0 | 11 | 2 |
Earnings | ||||
Quarter Ending Jun-18 | 0 | 0 | 1 | 1 |
Quarter Ending Sep-18 | 0 | 0 | 1 | 1 |
Year Ending Dec-18 | 0 | 0 | 6 | 7 |
Year Ending Dec-19 | 0 | 0 | 8 | 5 |
- BRIEF-Sino Biopharmaceutical Announces Proposed Bonus Issue Of Shares
- BRIEF-Sino Biopharmaceutical Says FY Profit Attributable Up 32.6 Pct
- BRIEF-Sino Biopharmaceutical Co Announces Acquisition of Sino Biopharm Beijing & Super Demand
- BRIEF-Sino Biopharmaceutical Product Granted Drug Registration Approval By State FDA Of China
- BRIEF-Sino Biopharmaceutical posts 9-month net profit attributable of RMB1.80 bln